Informatietype:
Webinar
Thema:
Metabolic and immune health
1 episode

In vitro microbiome and ex vivo intestinal models for gut health

Watch the webinar where we introduce our latest developments in in vitro models for the study of gut microbiota dynamics and host intestinal tissue response.

Microbiome modulation and activity, and intestinal wall function

Gut health is a key factor in our overall health and well-being. The gut microbiome that inhabits the digestive environment of the gut lumen contributes to intestinal homeostasis. Food products, drugs, probiotics and other factors can influence the function of the gut wall and/or microbiome.

Our translational models can be used to study the impact of your product on gut microbiota and host tissue response and can help to evaluate and boost product innovation at an early stage. Our in vitro and ex vivo gut model systems provide the unique opportunity to screen different lead compounds, ingredients and solutions for specific target populations (obese, elderly, infants) and evaluate their potential to promote health.

Get inspired

13 resultaten, getoond 1 t/m 5

Ancora Health develops personal diabetes plan with 360 methodology

Informatietype:
Insight
11 May 2023

With the help of TNO's knowledge of diabetic typing, Ancora Health wants to implement a diabetes lifestyle programme within healthcare.

Read more
over Ancora Health develops personal diabetes plan with 360 methodology

MixMasters uses TNO phenotype test to offer personalised nutrition

Informatietype:
Insight
11 May 2023

TNO is helping MixMasters answer the question 'How can we personalise while remaining user-friendly?' Moreover, during their collaboration, the idea for a new concept was born: FoodiYou.

Read more
over MixMasters uses TNO phenotype test to offer personalised nutrition

Personalised Health: Take it personal

Informatietype:
Insight
17 April 2023

TNO helps companies develop scientifically based personalised health applications. Knowledge is translated into applications by using a systems approach, and personalised health is put into practice. An example of this is the collaboration with Gabriele Ronnett of Johnson & Johnson Consumer Health Company.

Read more
over Personalised Health: Take it personal

Personalised Health: From science to market

Informatietype:
Webinar
14 April 2023
0 episodes

Are you interested in developing personalised health in order to contribute to a healthier society? Get inspired by the experience of companies that already innovate with us. Watch this interactive webinar for the latest insights in personalised health: from science to market.

Read more
over Personalised Health: From science to market

Public Private Partnership supports intestinal health in early life

Informatietype:
News
28 February 2023

Public Private Partnership Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.

Read more
over Public Private Partnership supports intestinal health in early life